APO Research
Talk to an analyst

APO RESEARCH · REPORT

Arteriovenous Fistula Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Arteriovenous Fistula Treatment Market Analysis and Forecast 2026-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchArteriovenous Fistula Treatment Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Arteriovenous Fistula Treatment Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Arteriovenous Fistula Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Arteriovenous Fistula Treatment Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Arteriovenous Fistula Treatment Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Arteriovenous Fistula Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Arteriovenous Fistula Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Arteriovenous Fistula Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Arteriovenous Fistula Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Arteriovenous Fistula Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Arteriovenous Fistula Treatment include Teleflex Incorporated, Medtronic, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen Ag, Poly Medicure Limited, NxStage Medical, Cook Medical and Becton Dickinson, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Arteriovenous Fistula Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Arteriovenous Fistula Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Arteriovenous Fistula Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Arteriovenous Fistula Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Arteriovenous Fistula Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Arteriovenous Fistula Treatment revenue, projected growth trends, production technology, application and end-user industry.

Arteriovenous Fistula Treatment Segment by Company

Teleflex Incorporated

Medtronic

Fresenius Medical Care AG & Co. KGaA

B. Braun Melsungen Ag

Poly Medicure Limited

NxStage Medical

Cook Medical

Becton Dickinson

Arteriovenous Fistula Treatment Segment by Type

Peripheral Arteriovenous Fistulas

Dural Arteriovenous Fistulas

Pial or Cerebral Arteriovenous Fistulas

Arteriovenous Fistula Treatment Segment by Application

Drugs

Surgery

Transcatheter Embolization

Ultrasound-guided Compression

Arteriovenous Fistula Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arteriovenous Fistula Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Arteriovenous Fistula Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arteriovenous Fistula Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Arteriovenous Fistula Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Arteriovenous Fistula Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Arteriovenous Fistula Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Arteriovenous Fistula Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Peripheral Arteriovenous Fistulas Major Player Table 3. Dural Arteriovenous Fistulas Major Player Table 4. Pial or Cerebral Arteriovenous Fistulas Major Player Table 5. Global Arteriovenous Fistula Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Drugs Major Player Table 7. Surgery Major Player Table 8. Transcatheter Embolization Major Player Table 9. Ultrasound-guided Compression Major Player Table 10. Arteriovenous Fistula Treatment Industry Trends Table 11. Arteriovenous Fistula Treatment Industry Drivers Table 12. Arteriovenous Fistula Treatment Industry Opportunities and Challenges Table 13. Arteriovenous Fistula Treatment Industry Restraints Table 14. Global Arteriovenous Fistula Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Arteriovenous Fistula Treatment Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Arteriovenous Fistula Treatment Market Share by Region (2021-2026) Table 17. Global Arteriovenous Fistula Treatment Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Arteriovenous Fistula Treatment Market Share by Region (2027-2032) Table 19. Global Arteriovenous Fistula Treatment Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Arteriovenous Fistula Treatment Revenue Market Share by Players (2021-2026) Table 21. Global Arteriovenous Fistula Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Arteriovenous Fistula Treatment Key Players Headquarters & Area Served Table 23. Global Arteriovenous Fistula Treatment Players, Product Type & Application Table 24. Global Arteriovenous Fistula Treatment Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Arteriovenous Fistula Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Arteriovenous Fistula Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Arteriovenous Fistula Treatment Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Arteriovenous Fistula Treatment Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Arteriovenous Fistula Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Arteriovenous Fistula Treatment Revenue Market Share by Type (2027-2032) Table 32. Global Arteriovenous Fistula Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Arteriovenous Fistula Treatment Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Arteriovenous Fistula Treatment Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Arteriovenous Fistula Treatment Revenue Market Share by Application (2021-2026) Table 36. Global Arteriovenous Fistula Treatment Revenue Market Share by Application (2027-2032) Table 37. Teleflex Incorporated Company Information Table 38. Teleflex Incorporated Business Overview Table 39. Teleflex Incorporated Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Teleflex Incorporated Arteriovenous Fistula Treatment Product Portfolio Table 41. Teleflex Incorporated Recent Development Table 42. Medtronic Company Information Table 43. Medtronic Business Overview Table 44. Medtronic Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Medtronic Arteriovenous Fistula Treatment Product Portfolio Table 46. Medtronic Recent Development Table 47. Fresenius Medical Care AG & Co. KGaA Company Information Table 48. Fresenius Medical Care AG & Co. KGaA Business Overview Table 49. Fresenius Medical Care AG & Co. KGaA Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Fresenius Medical Care AG & Co. KGaA Arteriovenous Fistula Treatment Product Portfolio Table 51. Fresenius Medical Care AG & Co. KGaA Recent Development Table 52. B. Braun Melsungen Ag Company Information Table 53. B. Braun Melsungen Ag Business Overview Table 54. B. Braun Melsungen Ag Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. B. Braun Melsungen Ag Arteriovenous Fistula Treatment Product Portfolio Table 56. B. Braun Melsungen Ag Recent Development Table 57. Poly Medicure Limited Company Information Table 58. Poly Medicure Limited Business Overview Table 59. Poly Medicure Limited Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Poly Medicure Limited Arteriovenous Fistula Treatment Product Portfolio Table 61. Poly Medicure Limited Recent Development Table 62. NxStage Medical Company Information Table 63. NxStage Medical Business Overview Table 64. NxStage Medical Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. NxStage Medical Arteriovenous Fistula Treatment Product Portfolio Table 66. NxStage Medical Recent Development Table 67. Cook Medical Company Information Table 68. Cook Medical Business Overview Table 69. Cook Medical Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Cook Medical Arteriovenous Fistula Treatment Product Portfolio Table 71. Cook Medical Recent Development Table 72. Becton Dickinson Company Information Table 73. Becton Dickinson Business Overview Table 74. Becton Dickinson Arteriovenous Fistula Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Becton Dickinson Arteriovenous Fistula Treatment Product Portfolio Table 76. Becton Dickinson Recent Development Table 77. North America Arteriovenous Fistula Treatment Revenue by Type (2021-2026) & (US$ Million) Table 78. North America Arteriovenous Fistula Treatment Revenue by Type (2027-2032) & (US$ Million) Table 79. North America Arteriovenous Fistula Treatment Revenue by Application (2021-2026) & (US$ Million) Table 80. North America Arteriovenous Fistula Treatment Revenue by Application (2027-2032) & (US$ Million) Table 81. North America Arteriovenous Fistula Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. North America Arteriovenous Fistula Treatment Revenue by Country (2021-2026) & (US$ Million) Table 83. North America Arteriovenous Fistula Treatment Revenue by Country (US$ Million) & (2027-2032) Table 84. Europe Arteriovenous Fistula Treatment Revenue by Type (2021-2026) & (US$ Million) Table 85. Europe Arteriovenous Fistula Treatment Revenue by Type (2027-2032) & (US$ Million) Table 86. Europe Arteriovenous Fistula Treatment Revenue by Application (2021-2026) & (US$ Million) Table 87. Europe Arteriovenous Fistula Treatment Revenue by Application (2027-2032) & (US$ Million) Table 88. Europe Arteriovenous Fistula Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Europe Arteriovenous Fistula Treatment Revenue by Country (2021-2026) & (US$ Million) Table 90. Europe Arteriovenous Fistula Treatment Revenue by Country (US$ Million) & (2027-2032) Table 91. China Arteriovenous Fistula Treatment Revenue by Type (2021-2026) & (US$ Million) Table 92. China Arteriovenous Fistula Treatment Revenue by Type (2027-2032) & (US$ Million) Table 93. China Arteriovenous Fistula Treatment Revenue by Application (2021-2026) & (US$ Million) Table 94. China Arteriovenous Fistula Treatment Revenue by Application (2027-2032) & (US$ Million) Table 95. Asia Arteriovenous Fistula Treatment Revenue by Type (2021-2026) & (US$ Million) Table 96. Asia Arteriovenous Fistula Treatment Revenue by Type (2027-2032) & (US$ Million) Table 97. Asia Arteriovenous Fistula Treatment Revenue by Application (2021-2026) & (US$ Million) Table 98. Asia Arteriovenous Fistula Treatment Revenue by Application (2027-2032) & (US$ Million) Table 99. Asia Arteriovenous Fistula Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Asia Arteriovenous Fistula Treatment Revenue by Region (US$ Million) & (2021-2026) Table 101. Asia Arteriovenous Fistula Treatment Revenue by Region (US$ Million) & (2027-2032) Table 102. SAMEA Arteriovenous Fistula Treatment Revenue by Type (2021-2026) & (US$ Million) Table 103. SAMEA Arteriovenous Fistula Treatment Revenue by Type (2027-2032) & (US$ Million) Table 104. SAMEA Arteriovenous Fistula Treatment Revenue by Application (2021-2026) & (US$ Million) Table 105. SAMEA Arteriovenous Fistula Treatment Revenue by Application (2027-2032) & (US$ Million) Table 106. SAMEA Arteriovenous Fistula Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. SAMEA Arteriovenous Fistula Treatment Revenue by Country (2021-2026) & (US$ Million) Table 108. SAMEA Arteriovenous Fistula Treatment Revenue by Country (US$ Million) & (2027-2032) Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Arteriovenous Fistula Treatment Image Figure 2. Global Arteriovenous Fistula Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Arteriovenous Fistula Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Peripheral Arteriovenous Fistulas Image Figure 5. Dural Arteriovenous Fistulas Image Figure 6. Pial or Cerebral Arteriovenous Fistulas Image Figure 7. Global Arteriovenous Fistula Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Arteriovenous Fistula Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 9. Drugs Image Figure 10. Surgery Image Figure 11. Transcatheter Embolization Image Figure 12. Ultrasound-guided Compression Image Figure 13. Global Arteriovenous Fistula Treatment Market Size (US$ Million) & (2021-2032) Figure 14. Global Arteriovenous Fistula Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Arteriovenous Fistula Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Arteriovenous Fistula Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Arteriovenous Fistula Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Arteriovenous Fistula Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Arteriovenous Fistula Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Arteriovenous Fistula Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Arteriovenous Fistula Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Arteriovenous Fistula Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America Arteriovenous Fistula Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Arteriovenous Fistula Treatment Revenue Share by Type (2021-2032) Figure 26. North America Arteriovenous Fistula Treatment Revenue Share by Application (2021-2032) Figure 27. North America Arteriovenous Fistula Treatment Revenue Share by Country (2021-2032) Figure 28. United States Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Arteriovenous Fistula Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Arteriovenous Fistula Treatment Revenue Share by Type (2021-2032) Figure 33. Europe Arteriovenous Fistula Treatment Revenue Share by Application (2021-2032) Figure 34. Europe Arteriovenous Fistula Treatment Revenue Share by Country (2021-2032) Figure 35. Germany Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Arteriovenous Fistula Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Arteriovenous Fistula Treatment Revenue Share by Type (2021-2032) Figure 45. China Arteriovenous Fistula Treatment Revenue Share by Application (2021-2032) Figure 46. Asia Arteriovenous Fistula Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Arteriovenous Fistula Treatment Revenue Share by Type (2021-2032) Figure 48. Asia Arteriovenous Fistula Treatment Revenue Share by Application (2021-2032) Figure 49. Asia Arteriovenous Fistula Treatment Revenue Share by Region (2021-2032) Figure 50. Japan Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Arteriovenous Fistula Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Arteriovenous Fistula Treatment Revenue Share by Type (2021-2032) Figure 58. SAMEA Arteriovenous Fistula Treatment Revenue Share by Application (2021-2032) Figure 59. SAMEA Arteriovenous Fistula Treatment Revenue Share by Country (2021-2032) Figure 60. Brazil Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Arteriovenous Fistula Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Peripheral Arteriovenous Fistulas
  • Dural Arteriovenous Fistulas
  • Pial or Cerebral Arteriovenous Fistulas
Applications
  • Drugs
  • Surgery
  • Transcatheter Embolization
  • Ultrasound-guided Compression
Companies covered
  • Teleflex Incorporated
  • Medtronic
  • Fresenius Medical Care AG & Co. KGaA
  • B. Braun Melsungen Ag
  • Poly Medicure Limited
  • NxStage Medical
  • Cook Medical
  • Becton Dickinson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Arteriovenous Fistula Treatment Market by Type
  3. 1.2.1 Global Arteriovenous Fistula Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Peripheral Arteriovenous Fistulas
  5. 1.2.3 Dural Arteriovenous Fistulas
  6. 1.2.4 Pial or Cerebral Arteriovenous Fistulas
  7. 1.3 Arteriovenous Fistula Treatment Market by Application
  8. 1.3.1 Global Arteriovenous Fistula Treatment Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Drugs
  10. 1.3.3 Surgery
  11. 1.3.4 Transcatheter Embolization
  12. 1.3.5 Ultrasound-guided Compression
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Arteriovenous Fistula Treatment Market Dynamics
  1. 2.1 Arteriovenous Fistula Treatment Industry Trends
  2. 2.2 Arteriovenous Fistula Treatment Industry Drivers
  3. 2.3 Arteriovenous Fistula Treatment Industry Opportunities and Challenges
  4. 2.4 Arteriovenous Fistula Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Arteriovenous Fistula Treatment Market Perspective (2021-2032)
  2. 3.2 Global Arteriovenous Fistula Treatment Growth Trends by Region
  3. 3.2.1 Global Arteriovenous Fistula Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Arteriovenous Fistula Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Arteriovenous Fistula Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Arteriovenous Fistula Treatment Revenue by Players
  2. 4.1.1 Global Arteriovenous Fistula Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Arteriovenous Fistula Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Arteriovenous Fistula Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Arteriovenous Fistula Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Arteriovenous Fistula Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Arteriovenous Fistula Treatment Players, Product Type & Application
  8. 4.5 Global Arteriovenous Fistula Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Arteriovenous Fistula Treatment Market CR5 and HHI
  11. 4.6.3 2025 Arteriovenous Fistula Treatment Tier 1, Tier 2, and Tier 3
5 Arteriovenous Fistula Treatment Market Size by Type
  1. 5.1 Global Arteriovenous Fistula Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Arteriovenous Fistula Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Arteriovenous Fistula Treatment Revenue Market Share by Type (2021-2032)
6 Arteriovenous Fistula Treatment Market Size by Application
  1. 6.1 Global Arteriovenous Fistula Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Arteriovenous Fistula Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Arteriovenous Fistula Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Teleflex Incorporated
  2. 7.1.1 Teleflex Incorporated Company Information
  3. 7.1.2 Teleflex Incorporated Business Overview
  4. 7.1.3 Teleflex Incorporated Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Teleflex Incorporated Arteriovenous Fistula Treatment Product Portfolio
  6. 7.1.5 Teleflex Incorporated Recent Developments
  7. 7.2 Medtronic
  8. 7.2.1 Medtronic Company Information
  9. 7.2.2 Medtronic Business Overview
  10. 7.2.3 Medtronic Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Medtronic Arteriovenous Fistula Treatment Product Portfolio
  12. 7.2.5 Medtronic Recent Developments
  13. 7.3 Fresenius Medical Care AG & Co. KGaA
  14. 7.3.1 Fresenius Medical Care AG & Co. KGaA Company Information
  15. 7.3.2 Fresenius Medical Care AG & Co. KGaA Business Overview
  16. 7.3.3 Fresenius Medical Care AG & Co. KGaA Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Fresenius Medical Care AG & Co. KGaA Arteriovenous Fistula Treatment Product Portfolio
  18. 7.3.5 Fresenius Medical Care AG & Co. KGaA Recent Developments
  19. 7.4 B. Braun Melsungen Ag
  20. 7.4.1 B. Braun Melsungen Ag Company Information
  21. 7.4.2 B. Braun Melsungen Ag Business Overview
  22. 7.4.3 B. Braun Melsungen Ag Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 B. Braun Melsungen Ag Arteriovenous Fistula Treatment Product Portfolio
  24. 7.4.5 B. Braun Melsungen Ag Recent Developments
  25. 7.5 Poly Medicure Limited
  26. 7.5.1 Poly Medicure Limited Company Information
  27. 7.5.2 Poly Medicure Limited Business Overview
  28. 7.5.3 Poly Medicure Limited Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Poly Medicure Limited Arteriovenous Fistula Treatment Product Portfolio
  30. 7.5.5 Poly Medicure Limited Recent Developments
  31. 7.6 NxStage Medical
  32. 7.6.1 NxStage Medical Company Information
  33. 7.6.2 NxStage Medical Business Overview
  34. 7.6.3 NxStage Medical Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 NxStage Medical Arteriovenous Fistula Treatment Product Portfolio
  36. 7.6.5 NxStage Medical Recent Developments
  37. 7.7 Cook Medical
  38. 7.7.1 Cook Medical Company Information
  39. 7.7.2 Cook Medical Business Overview
  40. 7.7.3 Cook Medical Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Cook Medical Arteriovenous Fistula Treatment Product Portfolio
  42. 7.7.5 Cook Medical Recent Developments
  43. 7.8 Becton Dickinson
  44. 7.8.1 Becton Dickinson Company Information
  45. 7.8.2 Becton Dickinson Business Overview
  46. 7.8.3 Becton Dickinson Arteriovenous Fistula Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Becton Dickinson Arteriovenous Fistula Treatment Product Portfolio
  48. 7.8.5 Becton Dickinson Recent Developments
8 North America
  1. 8.1 North America Arteriovenous Fistula Treatment Revenue (2021-2032)
  2. 8.2 North America Arteriovenous Fistula Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Arteriovenous Fistula Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Arteriovenous Fistula Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Arteriovenous Fistula Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Arteriovenous Fistula Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Arteriovenous Fistula Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Arteriovenous Fistula Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Arteriovenous Fistula Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Arteriovenous Fistula Treatment Revenue by Country
  11. 8.6.1 North America Arteriovenous Fistula Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Arteriovenous Fistula Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Arteriovenous Fistula Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Arteriovenous Fistula Treatment Revenue (2021-2032)
  2. 9.2 Europe Arteriovenous Fistula Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Arteriovenous Fistula Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Arteriovenous Fistula Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Arteriovenous Fistula Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Arteriovenous Fistula Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Arteriovenous Fistula Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Arteriovenous Fistula Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Arteriovenous Fistula Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Arteriovenous Fistula Treatment Revenue by Country
  11. 9.6.1 Europe Arteriovenous Fistula Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Arteriovenous Fistula Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Arteriovenous Fistula Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Arteriovenous Fistula Treatment Revenue (2021-2032)
  2. 10.2 China Arteriovenous Fistula Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Arteriovenous Fistula Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Arteriovenous Fistula Treatment Revenue by Type (2027-2032)
  5. 10.3 China Arteriovenous Fistula Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Arteriovenous Fistula Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Arteriovenous Fistula Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Arteriovenous Fistula Treatment Revenue by Application (2027-2032)
  9. 10.5 China Arteriovenous Fistula Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Arteriovenous Fistula Treatment Revenue (2021-2032)
  2. 11.2 Asia Arteriovenous Fistula Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Arteriovenous Fistula Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Arteriovenous Fistula Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Arteriovenous Fistula Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Arteriovenous Fistula Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Arteriovenous Fistula Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Arteriovenous Fistula Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Arteriovenous Fistula Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Arteriovenous Fistula Treatment Revenue by Country
  11. 11.6.1 Asia Arteriovenous Fistula Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Arteriovenous Fistula Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Arteriovenous Fistula Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Arteriovenous Fistula Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Arteriovenous Fistula Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Arteriovenous Fistula Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Arteriovenous Fistula Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Arteriovenous Fistula Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Arteriovenous Fistula Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Arteriovenous Fistula Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Arteriovenous Fistula Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Arteriovenous Fistula Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Arteriovenous Fistula Treatment Revenue by Country
  11. 12.6.1 SAMEA Arteriovenous Fistula Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Arteriovenous Fistula Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Arteriovenous Fistula Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst